CDK9 a Potential Target for Drug Development
Journal:
Medicinal Chemistry
Volume:
4
Page:
210-218
Author(s):
Fernanda Canduri, Patricia Cardoso Peres, Rafael Andrade Caceres and Walter Filgueira de Azevedo Jr.
Prolyl-Specific Peptidases and Their Inhibitors in Biological Processes
Journal:
Current Chemical Biology
Volume:
2
Page:
97-109
Author(s):
Lucienne Juillerat-Jeanneret
Non Peptidic Urotensin II Antagonists: Perspectives for a New Class of Drugs
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
6
Page:
80-91
Author(s):
Alessandro Cosenzi
Regulation of Lactosylceramide Synthase (Glucosylceramide β1→4 Galactosyltransferase); Implication as A Drug Target
Journal:
Current Drug Targets
Volume:
9
Page:
272-281
Author(s):
Subroto Chatterjee, Antonina Kolmakova and Mohanraj Rajesh
Golgi Localization of Glycosyltransferases Involved in Ganglioside Biosynthesis
Journal:
Current Drug Targets
Volume:
9
Page:
282-291
Author(s):
Gerhild van Echten-Deckert and Mihaela Guravi
Promoter Structure and Transcriptional Regulation of Human β-Galactoside α2, 3-Sialyltransferase Genes
Journal:
Current Drug Targets
Volume:
9
Page:
310-316
Author(s):
Akiyoshi Taniguchi
Cloning and Transcriptional Regulation of Genes Responsible for Synthesis of Gangliosides
Journal:
Current Drug Targets
Volume:
9
Page:
317-324
Author(s):
Guichao Zeng and Robert K. Yu
Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?
Journal:
Current Gene Therapy
Volume:
8
Page:
66-78
Author(s):
Sara A. Collins, Barbara-ann Guinn, Patrick T. Harrison, Martina F. Scallan, Gerald C. O'Sullivan and Mark Tangney
ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
978-990
Author(s):
R. Schmidmaier and P. Baumann
Role of Advanced Glycation End Products in Diabetic Neuropathy
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
953-961
Author(s):
Kazuhiro Sugimoto, Minoru Yasujima and Soroku Yagihashi